<DOC>
	<DOCNO>NCT02114554</DOCNO>
	<brief_summary>Mitochondrial disease multisystem disorder present wide range clinical manifestation . Mitochondrial DNA nt3243A &gt; G mutation one common mutation see mitochondrial disease . Syndromes associated mutation include mitochondrial encephalopathy , lactic acidosis , stroke-like episode ( MELAS ) , maternally inherit diabetes deafness ( MIDD ) , myoclonic epilepsy rag red fiber ( MERRF ) , chronic progressive external ophthalmoplegia ( CPEO ) . Clinical analysis mitochondrial DNA nt3243A &gt; G mutation Taiwan remain scarce . The present study aim investigate clinical feature prognostic factor patient mt3243A &gt; G mutation Taiwan .</brief_summary>
	<brief_title>Mitochondrial nt3243 A &gt; G Mutation Taiwan</brief_title>
	<detailed_description>Patients clinical feature . The study carry National Taiwan University hospital , tertiary medical center Taipei . The Medical Genetics Department National Taiwan University Hospital receive referral conduct genetic test hospital around Taiwan . We review medical chart patient document mitochondrial DNA nt3243 point mutation . Demographic data , age onset symptom , clinical feature ( include stroke , seizure-like episode , lactic level , diabetes mellitus , hear impairment , myopathy , electrocardiogram abnormality , chronic progressive external ophthalmoplegia ) , relevant family history , treatment , outcome record . Full MELAS phenotype define presence focal central nervous system event , either seizure , stroke , . Genetic analysis . Genomic DNA extract peripheral blood leukocyte use Puregene DNA purification kit ( Gentra Systems , Minneapolis , Minnesota , USA ) . Polymerase chain reaction ( PCR ) mitochondrial DNA nt3243 point mutation carry left primer 5'-cggagtaatccaggtcggtt-3 ' right primer 5'-ggaattgaacctctgactgt-3 ' . Presence mitochondrial DNA nt3243 A &gt; G mutation detect Hae III restriction enzyme digestion . Heteroplasmy mitochondrial nt3243A &gt; G mutation detect real-time amplification refractory mutation system quantitative PCR ( ARMS-qPCR ) assay previously report [ 19 ] . In brief , wild-type mutant-target primer , 500 nM , add 10-ml PCR reaction contain 1X KAPA SYBR® FAST ABI Prism® qPCR Master Mix ( KAPABIOSYSTEMS , Cat No . KK4603 ) 4 ng genomic DNA . Real-time PCR condition 2 min 50°C , 20 second 95°C , follow 40 cycle 15 second denaturation 95°C 30 second annealing/extension 62°C . Data cross point concentration fluorescent signal intensity PCR product record analyzed ABI StepOnePlusTM Real-Time PCR System ( Applied Biosystems ) StepOne software v2.1 ( Applied Biosystems ) . The threshold cycle ( CT value ) within linear exponential phase use construct standard curve measure original copy number DNA template . The percentage mutant mtDNA calculate use formula : Heteroplasmy % = 1/ ( 1+ 1/2△CT ) . Statistical analysis . SPSS 17.0 ( SPSS , Chicago , IL , USA ) use statistical analysis . Results give median range , mean ± 1 SD , appropriate . Student 's t-test use compare unpaired group . Fisher 's exact test use determine association two categorical variable . Cox-regression model use analyze possible prognostic factor . Inter-group difference outcome compare Kaplan-Meier estimate log-rank test . Pearson 's correlation use correlate heteroplasmy age diagnosis . A p value &lt; 0.05 consider statistically significant .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Deafness</mesh_term>
	<mesh_term>MELAS Syndrome</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Mitochondrial Diseases</mesh_term>
	<criteria>Patients mitochondrial DNA nt3243 A &gt; G mutation Patients without confirm mitochondrial DNA nt3243 A &gt; G mutation</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>MELAS</keyword>
	<keyword>MIDD</keyword>
	<keyword>Heteroplasmy</keyword>
</DOC>